Cargando…

High Acceptability of an Orally Dispersible Tablet Formulation by Children

There is a high unmet medical need for child-appropriate oral dosage forms. The acceptability of a novel placebo orally dispersible tablet formulation (pODT) was therefore evaluated. Monolithic tablets contain an inorganic calcium carbonate/calcium phosphate carrier material as the main excipient. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wagner-Hattler, Leonie, Kiene, Klara, Bielicki, Julia, Pfister, Marc, Puchkov, Maxim, Huwyler, Jörg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999602/ https://www.ncbi.nlm.nih.gov/pubmed/33807822 http://dx.doi.org/10.3390/children8030194

Ejemplares similares

Mechanisms of increased bioavailability through amorphous solid dispersions: a review
por: Schittny, Andreas, et al.
Publicado: (2019)

Meeting Challenges of Pediatric Drug Delivery: The Potential of Orally Fast Disintegrating Tablets for Infants and Children
por: Golhen, Klervi, et al.
Publicado: (2023)

Impact of Insoluble Separation Layer Mechanical Properties on Disintegration and Dissolution Kinetics of Multilayer Tablets
por: Yokoyama, Reiji, et al.
Publicado: (2020)

Modeling of Disintegration and Dissolution Behavior of Mefenamic Acid Formulation Using Numeric Solution of Noyes-Whitney Equation with Cellular Automata on Microtomographic and Algorithmically Generated Surfaces
por: Yokoyama, Reiji, et al.
Publicado: (2018)

Particle Forming Amorphous Solid Dispersions: A Mechanistic Randomized Pharmacokinetic Study in Humans
por: Schittny, Andreas, et al.
Publicado: (2021)

Spontaneous In Situ Formation of Liposomes from Inert Porous Microparticles for Oral Drug Delivery
por: Farzan, Maryam, et al.
Publicado: (2020)

Global sales of oral antibiotics formulated for children
por: Li, Grace, et al.
Publicado: (2020)

Formulation and Evaluation of Loperamide HCl Oro Dispersible Tablets
por: Alejandro, Blasco, et al.
Publicado: (2020)

Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial
por: Barda, Beatrice, et al.
Publicado: (2016)

Loading of Porous Functionalized Calcium Carbonate Microparticles: Distribution Analysis with Focused Ion Beam Electron Microscopy and Mercury Porosimetry
por: Farzan, Maryam, et al.
Publicado: (2019)

Formulation and evaluation of fast dissolving tablets of haloperidol solid dispersion
por: Eisa, Aya M., et al.
Publicado: (2022)

Relative Bioavailability of Orally Dispersible Tablet Formulations of Levo‐ and Racemic Praziquantel: Two Phase I Studies
por: Bagchus, Wilhelmina Maria, et al.
Publicado: (2018)

Formulation and evaluation of microsphere based oro dispersible tablets of itopride hcl
por: Shah, Sanjay, et al.
Publicado: (2012)

Effect of Food on the Pediatric Dispersible Tablet Formulations of TRIUMEQ and DOVATO in Healthy Adult Participants
por: Chandasana, Hardik, et al.
Publicado: (2023)

Acceptability of different oral formulations in infants and preschool children
por: van Riet-Nales, Diana A, et al.
Publicado: (2013)

Formulation and evaluation of fast dissolving tablet containing domperidone ternary solid dispersion
por: Patel, Dasharath M., et al.
Publicado: (2014)

Homogenization of Amorphous Solid Dispersions Prepared by Electrospinning in Low-Dose Tablet Formulation
por: Fülöp, Gergő, et al.
Publicado: (2018)

Metamizole is a Moderate Cytochrome P450 Inducer Via the Constitutive Androstane Receptor and a Weak Inhibitor of CYP1A2
por: Bachmann, Fabio, et al.
Publicado: (2021)

Effectiveness and medication acceptance of olanzapine disintegrating tablets compared to standard olanzapine tablets in acutely treated psychiatric patients
por: Czekalla, Jörg, et al.
Publicado: (2007)

Ingestibility and Formulation Quality of Lansoprazole Orally Disintegrating Tablets
por: Chono, Sumio, et al.
Publicado: (2016)

Pharmacokinetics and pharmacodynamics of an orally disintegrating tablet formulation of dexlansoprazole
por: Kukulka, Michael, et al.
Publicado: (2016)

Formulation and Taste Masking of Ranitidine Orally Disintegrating Tablet
por: Hesari, Zahra, et al.
Publicado: (2016)

Formulation and development of paediatric orally disintegrating carbamazepine tablets
por: Canadell-Heredia, R, et al.
Publicado: (2022)

Revisiting dispersible milk-drug tablets as a solid lipid formulation in the context of digestion
por: Binte Abu Bakar, Syaza Y., et al.
Publicado: (2019)

Bioavailability Evaluation of Venetoclax Lower-Strength Tablets and Oral Powder Formulations to Establish Interchangeability with the 100 mg Tablet
por: Badawi, Mohamed, et al.
Publicado: (2022)

Design, Formulation, and Physicochemical Evaluation of Montelukast Orally Disintegrating Tablet
por: Aslani, Abolfazl, et al.
Publicado: (2016)

Predicting oral disintegrating tablet formulations by neural network techniques
por: Han, Run, et al.
Publicado: (2018)

Design, Formulation and Physicochemical Evaluation of Dimenhydrinate Orally Disintegrating Tablets
por: Aslani, Abolfazl, et al.
Publicado: (2018)

Can children swallow tablets? Outcome data from a feasibility study to assess the acceptability of different-sized placebo tablets in children (creating acceptable tablets (CAT))
por: Bracken, Louise, et al.
Publicado: (2020)

Renal Function in Patients with Thalassemia Major Receiving Exjade(®) Dispersible Tablets and a New Film-coated Tablet Formulation of Deferasirox (Nanojade(®))
por: Falahati, Vahid, et al.
Publicado: (2022)

Adherence to oral amoxicillin dispersible tablets in children with community-acquired pneumonia enrolled in clinical trials in Malawi
por: Ginsburg, Amy Sarah, et al.
Publicado: (2021)

Bioequivalence of the 4-mg Oral Granules and Chewable Tablet Formulations of Montelukast
por: Knorr, Barbara, et al.
Publicado: (2010)

Efficacy, Safety, and Palatability of RACTAB® Formulation Amlodipine Orally Disintegrating Tablets
por: Fukui-Soubou, Mari, et al.
Publicado: (2012)

Recent Formulation Advances and Therapeutic Usefulness of Orally Disintegrating Tablets (ODTs)
por: Chinwala, Maimoona
Publicado: (2020)

Development of oral dispersible tablets containing prednisolone nanoparticles for the management of pediatric asthma
por: Chen, Yi-Dan, et al.
Publicado: (2015)

Acceptability, adherence, and clinical outcomes, of amoxicillin dispersible tablets versus oral suspension in treatment of children aged 2–59 Months with pneumonia, Kenya: A cluster randomized controlled trial
por: Angwa, Linet M., et al.
Publicado: (2020)

Development of raft-forming liquid and chewable tablet formulations incorporating quercetin solid dispersions for treatment of gastric ulcers
por: Bunlung, Suputra, et al.
Publicado: (2021)

Itraconazole Amorphous Solid Dispersion Tablets: Formulation and Compaction Process Optimization Using Quality by Design Principles and Tools
por: Triboandas, Hetvi, et al.
Publicado: (2022)

Formulation and Bioequivalence of Two Valsartan Tablets After a Single Oral Administration
por: Zaid, Abdel Naser, et al.
Publicado: (2011)

Formulation and Characterization of Oral Mucoadhesive Chlorhexidine Tablets Using Cordia myxa Mucilage
por: Moghimipour, Eskandar, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_1e3ovn2j3ug5tlka66itqhipr2